SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001178913-24-002392
Filing Date
2024-08-02
Accepted
2024-08-02 16:31:06
Documents
1
Period of Report
2024-04-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 6994
  Complete submission text file 0001178913-24-002392.txt   8497
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Issuer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address KIRYAT HADASSAH MINRAV BUILDING, FIFTH FLOOR JERUSALEM L3 9112002
Business Address
Yaacov-Garbeli Dana (Reporting) CIK: 0001909822 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38556 | Film No.: 241171518